Page last updated: 2024-10-26

disulfiram and Dysmyelopoietic Syndromes

disulfiram has been researched along with Dysmyelopoietic Syndromes in 1 studies

Research Excerpts

ExcerptRelevanceReference
" Therefore, new therapeutic approaches are urgently needed for MDS patients harboring adverse prognostic factors."5.62Disulfiram/copper shows potent cytotoxic effects on myelodysplastic syndromes via inducing Bip-mediated apoptosis and suppressing autophagy. ( Bi, S; Chen, K; Deng, M; Feng, L; Guo, C; He, J; Jiang, Y; Li, Z; Pu, X; Shi, P; Song, H; Xu, B; Zha, J; Zhao, H, 2021)
" Therefore, new therapeutic approaches are urgently needed for MDS patients harboring adverse prognostic factors."1.62Disulfiram/copper shows potent cytotoxic effects on myelodysplastic syndromes via inducing Bip-mediated apoptosis and suppressing autophagy. ( Bi, S; Chen, K; Deng, M; Feng, L; Guo, C; He, J; Jiang, Y; Li, Z; Pu, X; Shi, P; Song, H; Xu, B; Zha, J; Zhao, H, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zha, J1
Bi, S1
Deng, M1
Chen, K1
Shi, P1
Feng, L1
He, J1
Pu, X1
Guo, C1
Zhao, H1
Li, Z1
Jiang, Y1
Song, H1
Xu, B1

Other Studies

1 other study available for disulfiram and Dysmyelopoietic Syndromes

ArticleYear
Disulfiram/copper shows potent cytotoxic effects on myelodysplastic syndromes via inducing Bip-mediated apoptosis and suppressing autophagy.
    European journal of pharmacology, 2021, Jul-05, Volume: 902

    Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Cell Cycle; Cell Line, Tumor; Cell Proliferati

2021